Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.4.1.133 extracted from

  • Bakker, H.; Rouwendal, G.J.; Karnoup, A.S.; Florack, D.E.; Stoopen, G.M.; Helsper, J.P.; van Ree, R.; van Die, I.; Bosch, D.
    An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes (2006), Proc. Natl. Acad. Sci. USA, 103, 7577-7582.
    View publication on PubMedView publication on EuropePMC
Search for more literature for 2.4.1.133

Cloned(Commentary)

Cloned (Comment) Organism
expression of a hybrid enzyme (called xylGalT), consisting of the N-terminal domain of Arabidopsis thaliana xylosyltransferase and the catalytic domain of human beta-1,4-galactosyltransferase I (GalT) in tobacco causes a sharp reduction of N-glycans with potentially immunogenic corebound xylose (Xyl) and fucose (Fuc) residues Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens P15291
-
-

Synonyms

Synonyms Comment Organism
beta-1,4-galactosyltransferase I
-
 Homo sapiens